PASKALIUM Drug Patent Profile
✉ Email this page to a colleague
When do Paskalium patents expire, and what generic alternatives are available?
Paskalium is a drug marketed by Glenwood and is included in one NDA.
The generic ingredient in PASKALIUM is potassium aminosalicylate. There are two hundred and forty drug master file entries for this compound. Additional details are available on the potassium aminosalicylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PASKALIUM?
- What are the global sales for PASKALIUM?
- What is Average Wholesale Price for PASKALIUM?
Summary for PASKALIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 6 |
| DailyMed Link: | PASKALIUM at DailyMed |
US Patents and Regulatory Information for PASKALIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenwood | PASKALIUM | potassium aminosalicylate | CAPSULE;ORAL | 009395-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenwood | PASKALIUM | potassium aminosalicylate | TABLET;ORAL | 009395-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
